Medication info
Rivator 2 mg Tablets (Pitavastatin Calcium Hydrate)

Rivator 2 mg Tablets (Pitavastatin Calcium Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium Hydrate›2mg / 1 tablet
Manufacturer / importer
Boryung Biopharma Co., Ltd.
Appearance
Very light yellowish-red, round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202001532 · Approved 2020.03.05 · Insurance code 670502030

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients receiving this medication before and during treatment must follow a standard cholesterol-lowering diet. The usual initial dose for adults is 1–2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 mg daily. Depending on LDL cholesterol levels, treatment goals, and the patient's response, the dose should be adjusted as appropriate at intervals of 4 weeks or longer. The therapeutic effect of this medication is maintained with continued administration.

Ingredients

Manufacturer
Boryung Biopharma Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • increased LDL cholesterol
  • increased Apo-B protein
  • increased triglyceride level
View approved original text

This medication assists in lowering total cholesterol, LDL cholesterol, Apo-B protein, and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia as an adjunct to diet therapy. It also works to increase HDL cholesterol, the good cholesterol. Through this, the medication effectively controls blood lipid levels and helps reduce the risk of cardiovascular diseases. Thus, this drug plays an important role in managing dyslipidemia and contributes to maintaining healthy blood vessels.

How to take

Adult dose

Patients receiving this medication before and during treatment must follow a standard cholesterol-lowering diet. The usual initial dose for adults is 1–2 mg of pitavastatin calcium once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased to a maximum of 4 mg daily. Depending on LDL cholesterol levels, treatment goals, and the patient's response, the dose should be adjusted as appropriate at intervals of 4 weeks or longer. The therapeutic effect of this medication is maintained with continued administration.

Precautions

This medication should not be used in patients who have had allergic reactions to specific components, those with severely impaired liver function, or patients with active liver diseases. It should not be administered to women who are pregnant, may become pregnant, or are breastfeeding, nor to children. Patients allergic to soybean oil, soy, or peanuts should also not take this medication. Patients with kidney or liver issues, elderly patients, or those with hypothyroidism or a history of muscle disorders should use this medication with caution. In particular, when taken together with fibrate drugs or niacin, muscle damage and kidney function deterioration may occur, so caution is advised. If symptoms like muscle pain, muscle weakness, or severe fatigue develop during treatment, you should consult your doctor immediately. Regular liver function tests should be performed, and if any abnormalities are found, medication may need to be discontinued. Rarely, allergic symptoms such as skin rashes, itching, and hives may occur, and treatment should be stopped if such symptoms arise. This medication may show abnormal findings such as thrombocytopenia or elevated liver enzyme levels in blood tests, so regular testing is necessary. Some patients may experience side effects such as sleep disturbances, headache, dizziness, and indigestion. This medication should not be used during pregnancy and breastfeeding, as it may be harmful to the fetus or infant. Safety and effectiveness have not been established in children, so it is not used in this population. This medicine should be stored out of reach of children and should not be transferred from its original container to another container. Additionally, dietary changes and exercise should be attempted before medication, and blood lipid levels should be monitored regularly during treatment to confirm therapeutic effects. This medication may interact with other drugs, so if you are taking any other medications, be sure to inform your healthcare provider.

Side effects

  • Abdominal pain
  • rash
  • fatigue
  • paralysis
  • itching
  • myalgia
  • weakness
  • elevated CPK levels
  • increased myoglobin in blood and urine
  • acute renal failure
Show 78 more
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • hives
  • erythema
  • angioedema
  • elevated bilirubin
  • increased cholinesterase
  • elevated AST
  • elevated ALT
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • stiffness
  • drowsiness
  • insomnia
  • headache
  • heavy head sensation
  • dizziness
  • thirst
  • indigestion
  • abdominal bloating
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • discomfort in the stomach
  • diarrhea
  • granulocytopenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • elevated globulin
  • positive Coombs test
  • anemia
  • frequent urination
  • elevated BUN
  • increased serum creatinine
  • decreased aldosterone
  • elevated aldosterone
  • increased adrenal corticoid hormone
  • elevated cortisol
  • decreased testosterone
  • muscle cramps
  • loss of strength
  • palpitations
  • fatigue
  • skin pain
  • burning sensation
  • arthralgia
  • edema
  • visual disturbances
  • photophobia
  • hearing loss
  • hematuria
  • elevated uric acid levels
  • increased serum potassium and phosphorus
  • dysgeusia
  • sleep disturbances
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • immune-mediated necrotizing myopathy
  • severe myasthenia gravis
  • oculomotor weakness
  • facial edema
  • arm edema
  • hypersensitivity
  • headache
  • skin tingling
  • loss of appetite
  • elevated blood pressure
  • chest discomfort
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication can be sensitive to light, so it should be stored in a container that does not allow light to pass through. Additionally, it is important to maintain a temperature between 1 and 30 degrees Celsius when storing the medication, which will help preserve its efficacy.

Appearance and packaging

Appearance

Very light yellowish-red, round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.